Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1
Open Access
- 15 November 1999
- journal article
- research article
- Published by Springer Nature in The EMBO Journal
- Vol. 18 (22) , 6462-6471
- https://doi.org/10.1093/emboj/18.22.6462
Abstract
The growth‐suppressive properties of p53 are controlled by posttranslational modifications and by regulation of its turnover rate. Here we show that p53 can be modified in vitro and in vivo by conjugation to the small ubiquitin‐like protein SUMO‐1. A lysine residue at amino acid position 386 of p53 is required for this previously undescribed modification, strongly suggesting that this lysine residue serves as the major attachment site for SUMO‐1. Unlike ubiquitin, attachment of SUMO‐1 does not appear to target proteins for rapid degradation but rather, has been proposed to change the ability of the modified protein to interact with other cellular proteins. Accordingly, we provide evidence that conjugation of SUMO‐1 to wild‐type p53 results in an increased transactivation ability of p53. We suggest that posttranslational modification of p53 by SUMO‐1 conjugation provides a novel mechanism to regulate p53 activity.Keywords
This publication has 40 references indexed in Scilit:
- Identification of the Enzyme Required for Activation of the Small Ubiquitin-like Protein SUMO-1Journal of Biological Chemistry, 1999
- Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteinsOncogene, 1999
- The complexity of p53 modulation: emerging patterns from divergent signalsGenes & Development, 1998
- Protein regulation: Tag wrestling with relatives of ubiquitinCurrent Biology, 1998
- SUMO-1 Modification of IκBα Inhibits NF-κB ActivationMolecular Cell, 1998
- Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal DomainPublished by Elsevier ,1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2Cell, 1993
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993